105 related articles for article (PubMed ID: 12462348)
41. Tryptophan-Containing Cyclic Decapeptides with Activity against Plant Pathogenic Bacteria.
Camó C; Torné M; Besalú E; Rosés C; Cirac AD; Moiset G; Badosa E; Bardají E; Montesinos E; Planas M; Feliu L
Molecules; 2017 Oct; 22(11):. PubMed ID: 29072606
[TBL] [Abstract][Full Text] [Related]
42. Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach.
Monroc S; Badosa E; Besalú E; Planas M; Bardají E; Montesinos E; Feliu L
Peptides; 2006 Nov; 27(11):2575-84. PubMed ID: 16762457
[TBL] [Abstract][Full Text] [Related]
43. Analysis of antimicrobial peptides from porcine neutrophils.
Wessely-Szponder J; Majer-Dziedzic B; Smolira A
J Microbiol Methods; 2010 Oct; 83(1):8-12. PubMed ID: 20643166
[TBL] [Abstract][Full Text] [Related]
44. Anti-mycobacterial activity of a bis-sulfonamide.
Wilkinson BL; Bornaghi LF; Wright AD; Houston TA; Poulsen SA
Bioorg Med Chem Lett; 2007 Mar; 17(5):1355-7. PubMed ID: 17258454
[TBL] [Abstract][Full Text] [Related]
45. [Purification and characterization of antifungal peptide LP-1].
Liu Y; Xu Q; Chen Z
Wei Sheng Wu Xue Bao; 1999 Oct; 39(5):441-7. PubMed ID: 12555526
[TBL] [Abstract][Full Text] [Related]
46. Cyclic lipodepsipeptides: time for a concerted action to unlock their application potential?
Geudens N; Sinnaeve D; Martins JC
Future Med Chem; 2018 Mar; 10(5):479-481. PubMed ID: 29411995
[No Abstract] [Full Text] [Related]
47. Ferrocins, new iron-containing peptide antibiotics produced by bacteria. Isolation, characterization and structure elucidation.
Tsubotani S; Katayama N; Funabashi Y; Ono H; Harada S
J Antibiot (Tokyo); 1993 Feb; 46(2):287-93. PubMed ID: 8468244
[TBL] [Abstract][Full Text] [Related]
48. Cyclic lipoundecapeptide amphisin from Pseudomonas sp. strain DSS73.
Sørensen D; Nielsen TH; Christophersen C; Sørensen J; Gajhede M
Acta Crystallogr C; 2001 Sep; 57(Pt 9):1123-4. PubMed ID: 11588392
[TBL] [Abstract][Full Text] [Related]
49. Characterization of antimicrobial compounds produced by Pseudomonas aurantiaca S-1.
Mandryk MN; Kolomiets EI; Dey ES
Pol J Microbiol; 2007; 56(4):245-50. PubMed ID: 18254494
[TBL] [Abstract][Full Text] [Related]
50. WLIP and tolaasin I, lipodepsipeptides from Pseudomonas reactans and Pseudomonas tolaasii, permeabilise model membranes.
Coraiola M; Lo Cantore P; Lazzaroni S; Evidente A; Iacobellis NS; Dalla Serra M
Biochim Biophys Acta; 2006 Nov; 1758(11):1713-22. PubMed ID: 16925979
[TBL] [Abstract][Full Text] [Related]
51. Biological and molecular detection of toxic lipodepsipeptide-producing pseudomonas syringae strains and PCR identification in plants.
Bultreys A; Gheysen I
Appl Environ Microbiol; 1999 May; 65(5):1904-9. PubMed ID: 10223977
[TBL] [Abstract][Full Text] [Related]
52. Structure of syringotoxin, a bioactive metabolite of Pseudomonas syringae pv. syringae.
Ballio A; Bossa F; Collina A; Gallo M; Iacobellis NS; Paci M; Pucci P; Scaloni A; Segre A; Simmaco M
FEBS Lett; 1990 Sep; 269(2):377-80. PubMed ID: 2401362
[TBL] [Abstract][Full Text] [Related]
53. Pseudomonic acid: an antibiotic produced by Pseudomonas fluorescens.
Fuller AT; Mellows G; Woolford M; Banks GT; Barrow KD; Chain EB
Nature; 1971 Dec; 234(5329):416-7. PubMed ID: 5003547
[No Abstract] [Full Text] [Related]
54. Isolation and characterization of new peptide antibiotics, plusbacins A1-A4 and B1-B4.
Shoji J; Hinoo H; Katayama T; Matsumoto K; Tanimoto T; Hattori T; Higashiyama I; Miwa H; Motokawa K; Yoshida T
J Antibiot (Tokyo); 1992 Jun; 45(6):817-23. PubMed ID: 1500345
[TBL] [Abstract][Full Text] [Related]
55. Solution conformation of the Pseudomonas syringae pv. syringae phytotoxic lipodepsipeptide syringopeptin 25-A. Two-dimensional NMR, distance geometry and molecular dynamics.
Ballio A; Bossa F; Di Giorgio D; Di Nola A; Manetti C; Paci M; Scaloni A; Segre AL
Eur J Biochem; 1995 Dec; 234(3):747-58. PubMed ID: 8575431
[TBL] [Abstract][Full Text] [Related]
56. A new cyclic lipopeptide antibiotic, enamidonin.
Koshino S; Koshino H; Matsuura N; Kobinata K; Onose R; Isono K; Osada H
J Antibiot (Tokyo); 1995 Feb; 48(2):185-7. PubMed ID: 7706133
[No Abstract] [Full Text] [Related]
57. Regulation of syringomycin synthesis in Pseudomonas syringae pv. syringae and defined conditions for its production.
Gross DC
J Appl Bacteriol; 1985 Feb; 58(2):167-74. PubMed ID: 3980301
[TBL] [Abstract][Full Text] [Related]
58. Characterization of two Pseudomonas putida lipopeptide biosurfactants, putisolvin I and II, which inhibit biofilm formation and break down existing biofilms.
Kuiper I; Lagendijk EL; Pickford R; Derrick JP; Lamers GE; Thomas-Oates JE; Lugtenberg BJ; Bloemberg GV
Mol Microbiol; 2004 Jan; 51(1):97-113. PubMed ID: 14651614
[TBL] [Abstract][Full Text] [Related]
59. Corpeptins, new bioactive lipodepsipeptides from cultures of Pseudomonas corrugata.
Emanuele MC; Scaloni A; Lavermicocca P; Jacobellis NS; Camoni L; Di Giorgio D; Pucci P; Paci M; Segre A; Ballio A
FEBS Lett; 1998 Aug; 433(3):317-20. PubMed ID: 9744818
[TBL] [Abstract][Full Text] [Related]
60. Structural analysis of new syringopeptins by tandem mass spectrometry.
Isogai A; Iguchi H; Nakayama J; Kusai A; Takemoto JY; Suzuki A
Biosci Biotechnol Biochem; 1995 Jul; 59(7):1374-6. PubMed ID: 7670202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
